← Open Payments lookup

PAUL GEISE: Open Payments

NPI 1457895666 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,384 in 117 payments from 10 companies in 2025. Trend: 2023 $2,478 · 2024 $1,851 · 2025 $2,384

Food & beverage: $2,384
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.31$601
Alkermes, Inc.14$380
E.R. Squibb & Sons, L.L.C.20$344
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$284
Otsuka America Pharmaceutical, Inc.8$228
ABBVIE INC.10$158
Lundbeck LLC6$111
Neurocrine BioSciences, Inc.6$105
Vanda Pharmaceuticals Inc.4$105
Janssen Pharmaceuticals, Inc3$68

Products named: UZEDY, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, LYBALVI, VRAYLAR, ARISTADA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.